(Tiper Stock Exchange) – Labomaran internationally active Italian nutraceutical company listed on the Euronext Growth Milan market, closed the first half with revenues consolidated equal to 53.4 million euros, up 27.8% compared to the same period of 2022 (41.8 million euros).
After the significant result achieved in the first quarter of the current year (+47%) thanks to the positive effect of a backlog of orders acquired in 2022, the figure incorporates a return to natural levels of growthwith an increase in Group revenues of approx 12% in the second quarter alone of 2023.
The performance was made 52% in international markets thanks to the contribution of all the companies of the Labomar Group, which have been able to seize every opportunity for growth, even in a context that remains complex and which sees general signs of
slowdown, due to inflationary pressure and the reduced purchasing power of final consumers.
In the first half of 2023 the turnover of the parent company Labomar alone amounted to approximately 39.6 million euros, recording a 28.2% increase compared to the same period in 2022.
In the second quarter these trends petered out and it is expected to continue in a similar way in the final part of 2023where a progressive normalization of intermediate stock levels is expected.